[Factors influencing initiation of antiretroviral treatment for people living with HIV in approved HIV treatment centres of Bamenda and Bertoua in Cameroon].
作者信息
Mbopi-Keou Francois-Xavier, Voundi Esther Voundi, Kalla Ginette Claude Mireille, Emah Irène, Angwafo Fru, Muna Walinjom
机构信息
Faculty of Medicine & Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon ; National Public Health Laboratory, Ministry of Public Health, Yaounde, Cameroon.
Faculty of Medicine & Biomedical Sciences, University of Yaounde I, Yaounde, Cameroon ; University Teaching Hospital, Yaounde, Cameroon.
出版信息
Pan Afr Med J. 2014 Jan 13;17:6. doi: 10.11604/pamj.2014.17.6.3221. eCollection 2014.
Abstract
摘要
相似文献
1
[Factors influencing initiation of antiretroviral treatment for people living with HIV in approved HIV treatment centres of Bamenda and Bertoua in Cameroon].
Pan Afr Med J. 2014 Jan 13;17:6. doi: 10.11604/pamj.2014.17.6.3221. eCollection 2014.
2
Level of adherence and associated factors among HIV-positive adolescents on antiretroviral therapy in Cameroon.
Afr J AIDS Res. 2020 Dec;19(4):269-275. doi: 10.2989/16085906.2020.1833055.
3
Mapping and size estimates of female sex workers in Cameroon: Toward informed policy for design and implementation in the national HIV program.
PLoS One. 2019 Feb 26;14(2):e0212315. doi: 10.1371/journal.pone.0212315. eCollection 2019.
4
[Clinical and immunological profile of HIV-infected patients at the initiation of antiretroviral therapy in Douala].
Bull Soc Pathol Exot. 2015 Oct;108(4):255-61. doi: 10.1007/s13149-015-0444-3. Epub 2015 Aug 22.
5
Viral load testing and the use of test results for clinical decision making for HIV treatment in Cameroon: An insight into the clinic-laboratory interface.
PLoS One. 2018 Jun 11;13(6):e0198686. doi: 10.1371/journal.pone.0198686. eCollection 2018.
6
Free access to antiretroviral treatment and protection against the risk of catastrophic health expenditure in people living with HIV: evidence from Cameroon.
BMC Health Serv Res. 2021 Apr 7;21(1):313. doi: 10.1186/s12913-021-06331-5.
7
Cohort profile: the Swiss HIV Cohort study.
Int J Epidemiol. 2010 Oct;39(5):1179-89. doi: 10.1093/ije/dyp321. Epub 2009 Nov 30.
8
Intimate partner violence against HIV-positive Cameroonian women: Prevalence, associated factors and relationship with antiretroviral therapy discontinuity-results from the ANRS-12288 EVOLCam survey.
Womens Health (Lond). 2019 Jan-Dec;15:1745506519848546. doi: 10.1177/1745506519848546.
9
[Access to the management of HIV infected children: Overview of the healthcare supply in Cameroon in 2014].
Rev Epidemiol Sante Publique. 2020 Aug;68(4):243-251. doi: 10.1016/j.respe.2020.05.008. Epub 2020 Jul 4.
10
Prevalence of renal dysfunction and associated risk factors among HIV patients on ART at the Bamenda Regional Hospital, Cameroon.
Int J STD AIDS. 2020 May;31(6):526-532. doi: 10.1177/0956462420901985. Epub 2020 Mar 30.
引用本文的文献
1
HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon.
Trop Med Infect Dis. 2020 Aug 24;5(3):136. doi: 10.3390/tropicalmed5030136.
本文引用的文献
1
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.
Lancet. 2006 Aug 5;368(9534):505-10. doi: 10.1016/S0140-6736(06)69158-7.
2
Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.
Reprod Health Matters. 2006 May;14(27):12-23. doi: 10.1016/S0968-8080(06)27232-X.
3
Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities.
Am J Public Health. 2005 Jan;95(1):18-22. doi: 10.2105/AJPH.2004.040121.
4
5
Trends of AIDS epidemic in Cameroon, 1986 through 1995.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 May 1;18(1):89-91. doi: 10.1097/00042560-199805010-00015.
Zotero 插件